Medical Device Antimicrobial Susceptibility Testing Market | Page 2

REPORT DESCRIPTION
Antimicrobial Susceptibility Testing Market – Overview
Clostridium difficile infections are the most widely recognized cause of hospital acquired infectious
diarrhea. There is a critical need for development of prevention vaccine for this disease. Clostridium
difficile, is a gram-positive bacterium, which produces an anaerobic toxin that is transmitted through fecal-
oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to
healthcare associated infection with clinical manifestation ranging from asymptomatic infection to watery
diarrhea or serious intestinal condition such as colitis and colonic perforation.
Growing C. difficile infections at healthcare facilities and antibiotic resistance to treatment drugs are
propelling demand for development of prophylactic options to reduce the risk of infection in vulnerable
patients. A 2013 bulletin published from the Centers for Disease Control and Prevention (CDC) outlined
Clostridium difficile as urgent antibiotic-resistance threats in the U.S.
© Coherent market Insights. All Rights Reserved